Min.Order / FOB Price:Get Latest Price
1 Gram |
Negotiable |
Tofacitinib Tofacitinib powder cas 477600-75-2
1.high quality:
quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.
2.reasonable price:
we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.
3.low moq:
no worry about the low moq, our moq is 1 gram or even lower.
4.good service.
fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.
5. fast shipping and secure courier.
we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.
Rheumatoid arthritis medications Tofacitinib
Specification
Tofacitinib
CAS NO. 477600-75-2
C16H20N6O
rheumatoid arthritis medications
COA
Product Name |
Tofacitinib |
||||||
Synonyms |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile;CP 690550;3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo(2,3-D)pyrimidin-4-yl-, (3R,4R)-; CP-690550(Tasocitinib,CP690550);CP 690550(Tasocitinib); Tasocitinib; 3-((3R,4R)-4-Methyl-3-(Me...;Tasocitinib (CP 690550) |
||||||
CAS |
477600-75-2 |
||||||
Molecular formula |
C16H20N6O |
||||||
Molecular Weight |
312.3696 |
||||||
Molecular Structure |
|||||||
Physical and Chemical Properties |
|
||||||
General Description |
Light yellow powder |
||||||
Usage |
Tofacitinib is used for the treatment of rheumatoid arthritis (RA), and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases. Also Tofacitinib is used for the prevention of organ transplant rejection. |
||||||
Packing |
25kg/drum |
||||||
Storage condition |
Tasocitinib should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. |
||||||
Specifications |
|||||||
Items |
Standard |
||||||
Appearance |
Light yellow powder |
||||||
Loss on drying |
≤0.2% |
||||||
Watere content(KF) |
≤0.2% |
||||||
Purity(by HPLC) |
NLT 98.0% |
||||||
NMR Spectrum |
Sample correspond to that of standard preparation |
||||||
Mass Spectrum |
312.37±0.5Da |
English Name |
CAS |
Dasatinib |
302962-49-8 |
Dasatinib monohydrate |
863127-77-9 |
Nilotinib |
641571-10-0 |
Nilotinib hydrochloride monohydrate |
923288-90-8 |
Ponatinib |
943319-70-8 |
Sorafenib |
284461-73-0 |
Sorafenib tosylate |
475207-59-1 |
Pomalidomide |
19171-19-8 |
Lapatinib |
231277-92-2 |
Lapatinib ditosylate |
388082-78-8 |
Nitisinone |
104206-65-7 |
Tofacitinib citrate |
540737-29-9 |
Pazopanib |
444731-52-6 |
Pazopanib hydrochloride |
635702-64-6 |
Osimertinib AZD9291 |
1421373-65-0 |
Osimertinib Mesylate(AZD9291) |
1421373-66-1 |
Trametinib |
871700-17-3 |
3-cycloproppyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione |
871700-24-2 |
3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)-2,4(1H,3H )-pyrimidinedione |
871700-22-0 |
N-(3-{[3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7 -trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl]amino}ph enyl)acetamide |
871700-25-3 |
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl 4-methylbenzenesulfonate |
871700-32-2 |
Bosentan |
147536-97-8 |
Lenalidomide |
191732-72-6 |
3-Methyl-6-nitro-1H-indazole |
6494-19-5 |
2,3-dimethyl-6-nitroindazole |
444731-73-1 |
2,3-dimethyl-2H-indazol-6-amine |
444731-72-0 |
2,3-dimethylindazol-6-amine HCl |
635702-60-2 |
N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine |
444731-74-2 |
2,3-dimethyl-2H-indazol-6-amine hydrochloride |
635702-60-2 |
Masitinib |
790299-79-5 |
2-bromo-1-pyridin-3-ylethanone hydrobromide |
17694-68-7 |
N-(2-Methyl-5-nitrophenyl)-4-(3-pyridinyl)-2-thiazolamine |
1048007-94-8 |
N-(2-methyl-5-nitrophenyl)-4-pyridin-3-yl-1,3-thiazol-2-amine |
1048007-94-8 |
Sorafenib tosylate |
475207-59-1 |
Erlotinib hydrochloride |
183319-69-9 |
Gefitinib |
184475-35-2 |
INCB28060 |
1029712-80-8 |
Cabozantinib L-Malate |
1140909-48-3 |
LDK378 |
1032900-25-6 |
Ceritinib dihydrochloride |
1380575-43-8 |
alectinib |
1256580-46-7 |
Lapatinib ditosylate |
388082-78-8 |
Crizotinib |
877399-52-5 |
Sunitinib Malate |
341031-54-7 |
Venetoclax |
1257044-40-8 |
Selumetinib |
606143-52-6 |
AZD3759 |
1626387-80-1 |
EAI045 |
1942114-09-1 |
Baricitinib |
1187594-09-7 |
Dovitinib |
915769-50-5 |
Regorafenib |
755037-03-7 |
Nintedanib |
656247-17-5 |
Nintedanib Ethanesulfonate Salt |
656247-18-6 |
Nintedanib |
656247-17-5 |
Lenvatinib |
417716-92-8 |
lenvatinib mesylate |
857890-39-2 |
PCI-32765 |
936563-96-1 |
Abemaciclib |
1231929-97-7 |
AP26113 |
1197958-12-5 |
Aptinib |
811803-05-1 |
Anlotinib |
1058156-90-3 |
AZD1775 |
955365-80-7 |
Packing and shipping
CAS NO:1224690-84-9
CAS NO:1010396-29-8
CAS NO:1165910-22-4
CAS NO:317318-70-0
CAS NO:841205-47-8
CAS NO:112809-51-5
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View